T. Iványi

621 total citations
22 papers, 488 citations indexed

About

T. Iványi is a scholar working on Endocrinology, Diabetes and Metabolism, Social Psychology and Molecular Biology. According to data from OpenAlex, T. Iványi has authored 22 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Social Psychology and 5 papers in Molecular Biology. Recurrent topics in T. Iványi's work include Diabetes Management and Research (12 papers), Diabetes Treatment and Management (11 papers) and Neuroendocrine regulation and behavior (7 papers). T. Iványi is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes Treatment and Management (11 papers) and Neuroendocrine regulation and behavior (7 papers). T. Iványi collaborates with scholars based in Hungary, United States and United Kingdom. T. Iványi's co-authors include Melanie J. Davies, V.M. Wiegant, D. de Wied, Zvonko Miličević, Paolo Pozzilli, Honghua Jiang, Paul Norwood, Juliana Bue‐Valleskey, Esteban Jódar and Ferenc László and has published in prestigious journals such as Diabetes Care, Life Sciences and European Journal of Endocrinology.

In The Last Decade

T. Iványi

22 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Iványi Hungary 13 328 147 116 88 57 22 488
Gen Hirasawa Japan 9 247 0.8× 102 0.7× 59 0.5× 29 0.3× 132 2.3× 9 473
M. McAloon-Dyke United States 6 363 1.1× 131 0.9× 188 1.6× 18 0.2× 64 1.1× 7 497
Enrica Chebat Italy 10 98 0.3× 89 0.6× 46 0.4× 38 0.4× 48 0.8× 22 358
Laura Contu United Kingdom 9 80 0.2× 126 0.9× 78 0.7× 35 0.4× 37 0.6× 19 415
Johanna Klement Germany 10 109 0.3× 69 0.5× 54 0.5× 61 0.7× 59 1.0× 17 386
J.B. Fishback United States 8 172 0.5× 45 0.3× 73 0.6× 55 0.6× 101 1.8× 11 355
S. Bélisle Canada 13 78 0.2× 109 0.7× 36 0.3× 53 0.6× 22 0.4× 35 377
Andreas Pfeiffer Germany 6 149 0.5× 55 0.4× 21 0.2× 17 0.2× 61 1.1× 17 443
Stephen A. South United States 7 383 1.2× 94 0.6× 29 0.3× 16 0.2× 26 0.5× 8 569
N. Lytras United Kingdom 11 354 1.1× 57 0.4× 49 0.4× 20 0.2× 119 2.1× 13 440

Countries citing papers authored by T. Iványi

Since Specialization
Citations

This map shows the geographic impact of T. Iványi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Iványi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Iványi more than expected).

Fields of papers citing papers by T. Iványi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Iványi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Iványi. The network helps show where T. Iványi may publish in the future.

Co-authorship network of co-authors of T. Iványi

This figure shows the co-authorship network connecting the top 25 collaborators of T. Iványi. A scholar is included among the top collaborators of T. Iványi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Iványi. T. Iványi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Orchard, Trevor J., Bertrand Cariou, Margery A. Connelly, et al.. (2017). The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes. Cardiovascular Diabetology. 16(1). 73–73. 4 indexed citations
3.
Brunt, Kate Van, Bradley Curtis, T. Iványi, et al.. (2016). Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin. Diabetes Therapy. 7(4). 793–807. 4 indexed citations
4.
5.
Ginsberg, Henry N., Bertrand Cariou, Trevor J. Orchard, et al.. (2016). Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials. Diabetes Obesity and Metabolism. 18(11). 1089–1092. 18 indexed citations
7.
Buse, John B., Helena W. Rodbard, Carlos Trescolí Serrano, et al.. (2015). Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5. Diabetes Care. 39(1). 92–100. 67 indexed citations
9.
Blak, Betina T., et al.. (2012). Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin. Diabetic Medicine. 29(7). e13–20. 43 indexed citations
11.
Brodows, Robert G., et al.. (2009). The effect of exenatide re-exposure on safety and efficacy. Peptides. 30(9). 1771–1774. 20 indexed citations
12.
Miličević, Zvonko, et al.. (2009). Effect of Two Starting Insulin Regimens in Patients with Type II Diabetes not Controlled on a Combination of Oral Antihyperglycemic Medications. Experimental and Clinical Endocrinology & Diabetes. 117(5). 223–229. 12 indexed citations
13.
Iványi, T., F. Laczi, G. Szabó, et al.. (2009). Stimulatory Effect of Intracerebroventricularly Administered Dopamine on Vasopressin Release in Rats. Experimental and Clinical Endocrinology & Diabetes. 88(6). 303–308. 3 indexed citations
14.
Iványi, T., Janos Dohanics, & Joseph G. Verbalis. (1995). Effect of Chronic Hyponatremia on Central and Peripheral Oxytocin and Vasopressin Secretion in Rats. Neuroendocrinology. 61(4). 412–420. 17 indexed citations
15.
Radó, J, et al.. (1995). [Repeated serious water intoxication in an aged patient. (Data on the relationship between the inappropriate antidiuretic hormone syndrome and the atrial natriuretic factor)].. PubMed. 136(4). 189–93. 1 indexed citations
16.
Laczi, F., T. Iványi, Zóltan Sarnyai, et al.. (1994). The role of central corticoliberin in the ether stress-induced secretion of neurohypophyseal hormones and corticosterone in the rat. Neuropeptides. 26(1). 33–37. 7 indexed citations
17.
Iványi, T., et al.. (1991). Solid-phase extraction of plasma vasopressin: evaluation, validation and application. Journal of Chromatography B Biomedical Sciences and Applications. 565(1-2). 159–171. 17 indexed citations
18.
Iványi, T., V.M. Wiegant, & D. de Wied. (1991). Differential effects of emotional and physical stress on the central and peripheral secretion of neurohypophysial hormones in male rats. Life Sciences. 48(13). 1309–1316. 44 indexed citations
19.
Pokorny, G, et al.. (1989). Renal Involvement in Patients with Primary Sjögren's Syndrome. Scandinavian Journal of Rheumatology. 18(4). 231–234. 20 indexed citations
20.
Laczi, F., T. Iványi, J. Julesz, Tamás Janáky, & Ferenc László. (1986). Plasma arginine-8-vasopressin responses to osmotic or histamine stimulation contribute to the differential diagnosis of central diabetes insipidus. European Journal of Endocrinology. 113(2). 168–174. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026